Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Elife. 2024 May 29;12:RP92511. doi: 10.7554/eLife.92511.
Alterations in the function of K channels such as the voltage- and Ca-activated K channel of large conductance (BK) reportedly promote breast cancer (BC) development and progression. Underlying molecular mechanisms remain, however, elusive. Here, we provide electrophysiological evidence for a BK splice variant localized to the inner mitochondrial membrane of murine and human BC cells (mitoBK). Through a combination of genetic knockdown and knockout along with a cell permeable BK channel blocker, we show that mitoBK modulates overall cellular and mitochondrial energy production, and mediates the metabolic rewiring referred to as the 'Warburg effect', thereby promoting BC cell proliferation in the presence and absence of oxygen. Additionally, we detect mitoBK and BK transcripts in low or high abundance, respectively, in clinical BC specimens. Together, our results emphasize, that targeting mitoBK could represent a treatment strategy for selected BC patients in future.
据报道,K 通道功能的改变,如电压和 Ca 激活的大电导钾通道(BK),可促进乳腺癌(BC)的发展和进展。然而,潜在的分子机制仍难以捉摸。在这里,我们提供了电生理学证据,证明存在一种位于鼠和人 BC 细胞(mitoBK)线粒体内部膜的 BK 剪接变体。通过基因敲低和敲除的组合,以及一种细胞渗透性 BK 通道阻断剂,我们表明 mitoBK 调节整体细胞和线粒体能量产生,并介导代谢重编程,称为“Warburg 效应”,从而促进 BC 细胞在有氧和无氧条件下的增殖。此外,我们在临床 BC 标本中分别以低丰度或高丰度检测到 mitoBK 和 BK 转录本。总之,我们的研究结果强调,针对 mitoBK 可能代表未来特定 BC 患者的一种治疗策略。